• 1
    Wallace DJ, Podell TE, Weiner JM et al. Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980. Am J Med 1982;72:20920.
  • 2
    Mojcik CF, Klippel JH. End-stage renal disease and systemic lupus erythematosus. Am J Med 1996;101:1007.
  • 3
    Nossent HC, Swaak TJ, Berden JH. Systemic lupus erythematosus: analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or continuous ambulatory peritoneal dialysis. Dutch working party on sle. Am J Med 1990;89:16974.
  • 4
    U.S. Renal Data System. USRDS 2008 Annual Data Report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2008.
  • 5
    Abusamieh M, Ash J. Atherosclerosis and systemic lupus erythematosus. Cardiol Rev 2004;12:26775.
  • 6
    Altieri P, Sau G, Cao R et al. Immunosuppressive treatment in dialysis patients. Nephrol Dial Transplant 2002;17(Suppl. 8):29.
  • 7
    Huang JW, Hung KY, Yen CJ et al. Systemic lupus erythematosus and peritoneal dialysis: outcomes and infectious complications. Perit Dial Int 2001;21:1437.
  • 8
    Cheigh JS, Kim H, Stenzel KH et al. Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity. Am J Kidney Dis 1990;16:18995.
  • 9
    Pollock CA, Ibels LS. Dialysis and transplantation in patients with renal failure due to systemic lupus erythematosus. The Australian and New Zealand experience. Aust N Z J Med 1987;17:3215.
  • 10
    Jarrett MP, Santhanam S, Del Greco F. The clinical course of end-stage renal disease in systemic lupus erythematosus. Arch Intern Med 1983;143:13536.
  • 11
    Coplon NS, Diskin CJ, Petersen J et al. The long-term clinical course of systemic lupus erythematosus in end-stage renal disease. N Engl J Med 1983;308:18690.
  • 12
    Rodby RA, Korbet SM, Lewis EJ. Persistence of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis. Am J Med 1987;83:6138.
  • 13
    Siu YP, Leung KT, Tong MK et al. Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2005;20:2797802.
  • 14
    Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:12717.
  • 15
    Lin JL, Lin-Tan DT, Yen TH et al. Blood lead levels, malnutrition, inflammation, and mortality in patients with diabetes treated by long-term hemodialysis. Am J Kidney Dis 2008;51:10715.
  • 16
    Hsu CW, Lin JL, Lin-Tan DT et al. Association of environmental cadmium exposure with inflammation and malnutrition in maintenance haemodialysis patients. Nephrol Dial Transplant 2009;24:12828.
  • 17
    Chen KH, Lin-Tan DT, Huang WH et al. Cardiothoracic ratio, malnutrition, inflammation, and two-year mortality in non-diabetic patients on maintenance hemodialysis. Kidney Blood Press Res 2008;31:14351.
  • 18
    Daugirdas JT. The post: pre-dialysis plasma urea nitrogen ratio to estimate k.T/v and npcr: mathematical modeling. Int J Artif Organs 1989;12:4119.
  • 19
    Twardowski ZJ, Nolph KD, Khanna R et al. Peritoneal equilibration test. Perit Dial Bull 1987;7:13847.
  • 20
    Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (roc) curve. Radiology 1982;143:2936.
  • 21
    Heimburger O, Qureshi AR, Blaner WS et al. Hand-grip muscle strength , lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis 2000;36:121325.
  • 22
    Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 1993;44:1159.
  • 23
    Chung SH, Heimburger O, Stenvinkel P et al. Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients. Perit Dial Int 2003;23:17483.
  • 24
    Heaf J. High transport and malnutrition-inflammation-atherosclerosis (MIA) syndrome. Perit Dial Int 2003;23:10910.
  • 25
    Chung SH, Heimbürger O, Lindholm B. Poor outcomes for fast transporters on PD: the rise and fall of a clinical concern. Semin Dial 2008;21:710.
  • 26
    Chung SH, Heimbürger O, Stenvinkel P et al. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients. Nephrol Dial Transplant 2003;18:5907.